肺功能下降与阻塞性睡眠呼吸暂停的关联:ALE 研究。
Association between lung function decline and obstructive sleep apnoea: the ALEC study.
机构信息
Department of Respiratory, Allergy and Sleep Research, Akademiska Sjukhuset, Uppsala University, 751 85, Uppsala, Sweden.
Department of Respiratory Medicine and Allergology, Akademiska Sjukhuset, Uppsala, Sweden.
出版信息
Sleep Breath. 2021 Jun;25(2):587-596. doi: 10.1007/s11325-020-02086-1. Epub 2020 Jul 6.
PURPOSE
To study changes in lung function among individuals with a risk of obstructive sleep apnoea (OSA), and if asthma affected this relationship.
METHODS
We used data from the European Community Respiratory Health Survey II and III, a multicentre general population study. Participants answered questionnaires and performed spirometry at baseline and 10-year follow-up (n = 4,329 attended both visits). Subjects with high risk for OSA were identified from the multivariable apnoea prediction (MAP) index, calculated from BMI, age, gender, and OSA symptoms at follow-up. Asthma was defined as having doctor's diagnosed asthma at follow-up. Primary outcomes were changes in forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) from baseline to follow-up.
RESULTS
Among 5108 participants at follow-up, 991 (19%) had a high risk of OSA based on the MAP index. Participants with high OSA risk more often had wheeze, cough, chest tightness, and breathlessness at follow-up than those with low OSA risk. Lung function declined more rapidly in subjects with high OSA risk (low vs high OSA risk [mean ± SD]: FEV1 = - 41.3 ± 24.3 ml/year vs - 50.8 ± 30.1 ml/year; FVC = - 30.5 ± 31.2 ml/year vs - 45.2 ± 36.3 ml/year). Lung function decline was primarily associated with higher BMI and OSA symptoms. OSA symptoms had a stronger association with lung function decline among asthmatics, compared to non-asthmatics.
CONCLUSION
In the general population, a high probability of obstructive sleep apnoea was related to faster lung function decline in the previous decade. This was driven by a higher BMI and more OSA symptoms among these subjects. The association between OSA symptoms and lung function decline was stronger among asthmatics.
目的
研究阻塞性睡眠呼吸暂停(OSA)高危人群的肺功能变化,以及哮喘是否影响这种关系。
方法
我们使用了来自欧洲社区呼吸健康调查 II 和 III 的数据,这是一项多中心的一般人群研究。参与者在基线和 10 年随访时回答问卷并进行肺功能检查(n=4329 人参加了两次随访)。根据多变量呼吸暂停预测(MAP)指数,从 BMI、年龄、性别和随访时的 OSA 症状中确定 OSA 高危人群。哮喘定义为随访时被医生诊断为哮喘。主要结局是从基线到随访时用力呼气量 1 秒(FEV1)和用力肺活量(FVC)的变化。
结果
在随访的 5108 名参与者中,根据 MAP 指数,有 991 人(19%)有 OSA 高危。与低 OSA 风险组相比,高 OSA 风险组在随访时更常出现喘息、咳嗽、胸闷和呼吸困难。高 OSA 风险组的肺功能下降速度更快(低 vs 高 OSA 风险[平均±标准差]:FEV1=-41.3±24.3ml/年 vs -50.8±30.1ml/年;FVC=-30.5±31.2ml/年 vs -45.2±36.3ml/年)。肺功能下降主要与更高的 BMI 和 OSA 症状有关。与非哮喘患者相比,哮喘患者的 OSA 症状与肺功能下降的相关性更强。
结论
在一般人群中,阻塞性睡眠呼吸暂停的可能性较高与前十年肺功能下降较快有关。这是由于这些患者的 BMI 更高,OSA 症状更多。OSA 症状与肺功能下降之间的关联在哮喘患者中更强。